1. Akt inhibitor MK‐2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study. Issue 8 (1st June 2017) Authors: Larsen, Jeremy T.; Shanafelt, Tait D.; Leis, Jose F.; LaPlant, Betsy; Call, Tim; Pettinger, Adam; Hanson, Curtis; Erlichman, Charles; Habermann, Thomas Matthew; Reeder, Craig; Nikcevich, Daniel; Bowen, Deborah; Conte, Michael; Boysen, Justin; Secreto, Charla; Lesnick, Connie; Tschumper, Renee; Je... Journal: American journal of hematology Issue: Volume 92:Issue 8(2017:Aug.) Page Start: 759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403. Issue 6 (6th April 2020) Authors: Kaplan, Lawrence D.; Maurer, Matthew J.; Stock, Wendy; Bartlett, Nancy L.; Fulton, Noreen; Pettinger, Adam; Byrd, John C.; Blum, Kristie A.; LaCasce, Ann S.; Hsi, Eric D.; Liu, Yi Tian; Scott, David W.; Hurd, David; Ruppert, Amy S.; Hernandez‐Ilizaliturri, Francisco; Leonard, John P.; Cheson, Bru... Journal: American journal of hematology Issue: Volume 95:Issue 6(2020:Jun.) Page Start: 583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗